SEC Form 3 · accession 0001104659-15-077751
Voyager Therapeutics, Inc. · VYGR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeff Goater
Officer — SVP Finance, Bus. Development
Period of report
Nov 10, 2015
Accepted (ET)
Nov 10, 2015 · 7:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001640266
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 64,705 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $7.27 | holding | — | — | — | — | Apr 27, 2025 | Common Stock | 57,058 | — | D |
| Stock Option (Right to Buy)F2 | $8.33 | holding | — | — | — | — | Aug 25, 2025 | Common Stock | 5,882 | — | D |
Explanation of responses
- F1This option vests in 48 equal monthly installments, commencing on January 1, 2015.
- F2This option vests in 48 equal monthly installments, commencing on August 1, 2015.